dan 2163 has been researched along with desvenlafaxine succinate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hackett, LP; Ilett, KF; Kohan, R; Teoh, S; Watt, F | 1 |
| Chiron, S; Gomez, O; Manasfi, R; Perez, S; Tadić, D | 1 |
2 other study(ies) available for dan 2163 and desvenlafaxine succinate
| Article | Year |
|---|---|
Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression.
Topics: Adult; Amisulpride; Antidepressive Agents; Breast Feeding; Cyclohexanols; Depressive Disorder; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Lactation; Milk, Human; Sulpiride | 2010 |
Persistence of N-oxides transformation products of tertiary amine drugs at lab and field studies.
Topics: Amisulpride; Desvenlafaxine Succinate; Oxides; Pharmaceutical Preparations; Sulpiride; Tramadol; Venlafaxine Hydrochloride; Water; Water Pollutants, Chemical | 2022 |